Life ScienceCompany
The Medicines Company has acquired 6 companies of its own. A total of 3 acquisitions came from private equity firms. It has also divested 2 assets.
The Medicines Company’s largest acquisition to date was in 2013, when it acquired ProFibrix B.V. for $230M. It’s largest disclosed sale occurred in 2017, when it sold The Medicines Company - Infectious Disease Business to Melinta Therapeutics for $270M. The Medicines Company has acquired in 2 different US states, and 3 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).
Join Mergr and gain access to The Medicines Company’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity6
- M&A Sell Activity2
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
- M&A Advisors 5
Unlimited Searches
